SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Webhead who wrote (1664)6/7/1999 1:54:00 PM
From: Roudy  Read Replies (1) of 1762
 
Acquisition rumors are being posted on Yahoo. Here is one of them below;

Clues to what's happening
by:  <Picture: Sorry, I'm not available> DavidSage 759 of 762Assembled from public information:

1. IDEC has been looking to make a deal with one or more cancer therapy companies to round out it's business plan and build on it's oncology franchise and experienced sales force. The company has a history of successful collaborations.

2. ILEX needs an experienced marketing partner for Campath.

3. IDEC has explored San Antonio, TX as a possible site for expansion.

4. ILEX is located in San Antonio.

5. IDEC's Rituxan is a chimeric MoAb against CD-20 for the treatment of lymphoma and is being investigated against CLL.

6. ILEX's Campath is a humanized MoAb against CD-53 and is being investigated for the treatment of CLL.

7. ILEX has a relationship with the Burnham Institute, located just down the road from IDEC in La Jolla.

8. IDPH is recently trading in a very tight range around 55; ILXO is very steady at 10.

And these are heresay and anecdotal:

9. Various posters have been hinting at a deal for some time.

10. A deal seems to make a lot of sense for both companies.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News